IUGA 48th Annual Meeting: June 21-24, 2023, The Hague / The Netherlands

Abstract Sessions

Wednesday, September 2, 2020
03:15 p.m. - 03:35 p.m.
E-poster session 7 - Pelvic floor disorders: surgical management and complications
Moderator: Jan Willem de Leeuw (The Netherlands)
Safety of laparoscopic sacrocolpopexy and sacrohysteropexy in the elderly: Feasibility and outcomes (#223)
Speaker: Ohad Gluck (Israel)
Subjective change in pelvic floor symptoms during 3 years follow up in patients who underwent laproscopic sacrocolpopexy for pelvic organ prolapse (#224)
Speaker: Nao Muta (Japan)
The safety and efficacy of laparoscopic sacrocolpopexy/sacrohysteropexy and concurrent low ventral rectopexy - a prospective study (#225)
Speaker: Ohad Gluck (Israel)
A randomized control study on timing of midurethral sling during concomitant prolapse surgery: before or after apical suspension? (#226)
Speaker: Marisa Vega (USA)
Efficacy and safety of self-cut titanium-coated polypropylene mesh versus mesh-kit for transvaginal treatment of severe pelvic organ prolapse: a multi-center randomized pilot study (#228)
Speaker: Juan Chen (China)
Changing trends in surgical treatment of central compartment prolapse: 10-year tertiary centre experience (#229)
Speaker: Tamara Serdinšek (Slovenia)
Factors associated with mesh erosion and rate of occurrence: a ten-year experience in a Philippine Tertiary Training Hospital (#230)
Speaker: Mary Rani Cadiz (Philippines)
Results of vaginal mesh resection – a restrospective cohort (#231)
Speaker: Breffini Anglim (Canada)
03:15 p.m. - 03:55 p.m.
Long oral session 4 - Sexual function
Moderator: Svjetlana Lozo (USA)
Is vaginal laxity associated with vaginal parity or delivery mode? (#024)
Speaker: Susana Mikhail Mustafa (Australia)
Sexual activity and function in women with POP and high risk of recurrence, before and after laparoscopic versus vaginal mesh: a randomised controlled trial (#025)
Speaker: Sònia Anglès-Acedo (Spain)
Vaginal stenosis in women with treated cervical and endometrial cancer: cross-sectional study of vaginal measurements, sexual function and quality of life (#026)
Speaker: Luiz Gustavo Brito (Brazil)
Predictors of female sexual dysfunction in interstitial cystitis/bladder pain syndrome, other chronic pain conditions and healthy controls in the MAPP research network (#027)
Speaker: Renee Rolston (USA)
03:15 p.m. - 04:20 p.m.
Short oral session 9 - Pelvic floor disorders: conservative management
Moderator: Baerbel Junginger (Germany)
Attitudes and barriers to pelvic floor muscle exercises of women with stress urinary incontinence (#113)
Speaker: Sirirat Saritapirak (Thailand)
Fluids affecting bladder urgency and lower urinary symptoms (FABULUS): results from a randomized controlled trial (#114)
Speaker: Abigail Smith (USA)
A randomized controlled trial on the effect of preoperative pelvic floor muscle training on urinary and anal incontinence in women scheduled for pelvic organ prolapse surgery (#115)
Speaker: Seema Mathew (Norway)
Effect of vaginal estriol 0.03 mg with Lactobacillus acidophilus on incidence of bacterial vaginosis in patient using pessary for treatment of pelvic organ prolapse: a randomized controlled trial (#116)
Speaker: Keerati Chiengthong (Thailand)
Vaginal Erbium-Yag laser versus pelvic floor training for mild to moderate stress urinary incontinence: A pilot randomized controlled trial (#117)
Speaker: Sebastian Viguera (Chile)
Patient perceptions of an exercise training and healthy eating group program (ATHENA) for overweight and obese women with urinary incontinence: a qualitative descriptive study (#118)
Speaker: Zara Howard (Australia)
A feasibility study on the prevention of post-partum stress urinary incontinence by midwife-delivered antenatal pelvic floor muscle training: a cluster randomised controlled trial (#119)
Speaker: Ifeoma Offiah (United Kingdom)
Dose transcutaneous electrical stimulation treatment improve the pelvic floor function in post operative cervical cancer patients? (#120)
Speaker: Xiuli Sun (China)
Patients' satisfaction and safety of bulk injection therapy Urolastic® for treatment of stress urinary incontinence: a cross-sectional study (#122)
Speaker: Fenne Casteleijn (The Netherlands)
Pelvic floor muscle training with and without biofeedback in treatment of overactive bladder (#123)
Speaker: Achla Batra (India)
03:15 p.m. - 04:20 p.m.
Short oral session 12 - Miscellaneous
Moderator: Hugo van Eijndhoven (The Netherlands)
Is levator avulsion associated with vaginal laxity? (#159)
Speaker: Hans Peter Dietz (Australia)
The surgical outcomes and risk factors for failure of mid-urethral sling surgeries in elderly and old age women with urodynamic stress incontinence (#160)
Speaker: Rami Ibrahim (Jordan)
Association of overactive bladder (OAB) with social determinants of health (SDOH) (#161)
Speaker: Laura Tellechea (USA)
Fosfomycin susceptibility of uropathogens resistant to antibiotics used in peri-operative prophylaxis of urinary tract infection among female patients after urogyneacologycal surgery. (#162)
Speaker: Sara Wawrysiuk (Poland)
Robotic versus laparoscopic sacrocolpopexy: morbidity, anatomic results and long-term revision surgeries (#163)
Speaker: Rajeev Ramanah (France)
A multi-centre study of the impact of the mesh pause on women's choice of surgery for primary stress urinary incontinence. (#164)
Speaker: Fiona Reid (United Kingdom)
The association between nocturia and irritative bladder symptoms in women undergoing urodynamic testing (#165)
Speaker: Asad Rahim (United Kingdom)
Uroflowmetry on POD #1 after midurethral sling: a medium term voiding dysfunction predictor (#166)
Speaker: Javier Pizarro-Berdichevsky (Chile)
Long term pre to postoperative MRI changes in women with long-term surgical success versus anatomic failure (#167)
Speaker: Payton Schmidt (USA)
Pelvic floor ultrasound before and after surgery with and adjustable sling in patients with recurrent and complex urodynamic stress urinary incontinence (#168)
Speaker: Cristina Ros-Cerro (Spain)
Occult stress urinary incontinence (OSUI): Is it necessary to treat it when performing prolapse surgeries? (#169)
Speaker: Romina Suárez (Chile)
Age, parity and prolapse: interaction and influence on levator bowl volume (#170)
Speaker: Wenjin Cheng (USA)
The morbidity of lower urinary tract symptoms and related factors following Piver III radical hysterectomy for cervical cancer (#171)
Speaker: Fang An (China)


IUGA Office

Vivian Gies, IUGA Meeting Director
Zaanweg 119A
1521DS Wormerveer
The Netherlands
+31 75 647 63 65